|
TSPYL4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.48819964632219E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.12110370670871E-11 |
| Normal-vs-Stage2 |
2.08850000005256E-06 |
| Normal-vs-Stage3 |
1.85989999956782E-07 |
| Normal-vs-Stage4 |
3.20750000004644E-06 |
| Stage1-vs-Stage2 |
6.020600E-01 |
| Stage1-vs-Stage3 |
9.105800E-01 |
| Stage1-vs-Stage4 |
6.122000E-01 |
| Stage2-vs-Stage3 |
5.612200E-01 |
| Stage2-vs-Stage4 |
3.432400E-01 |
| Stage3-vs-Stage4 |
6.684200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.68210034579408E-10 |
| Normal-vs-AfricanAmerican |
5.32899946392718E-10 |
| Normal-vs-Asian |
1.9760999999674E-06 |
| Caucasian-vs-AfricanAmerican |
6.363800E-01 |
| Caucasian-vs-Asian |
1.857360E-01 |
| AfricanAmerican-vs-Asian |
1.221160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.30271357537504E-12 |
| Normal-vs-Female |
1.85885999999247E-05 |
| Male-vs-Female |
3.483800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.53269999312056E-09 |
| Normal-vs-Extreme_Weight |
1.22460042106809E-10 |
| Normal-vs-Obese |
5.10790000296524E-08 |
| Normal-vs-Extreme_Obese |
1.586840E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.088600E-01 |
| Normal_Weight-vs-Obese |
2.696600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.808800E-01 |
| Extreme_Weight-vs-Obese |
1.990970E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.946000E-01 |
| Obese-vs-Extreme_Obese |
9.004400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.06370000047585E-07 |
| Normal-vs-Age(41-60Yrs) |
8.30330000312074E-08 |
| Normal-vs-Age(61-80Yrs) |
5.03359576242701E-11 |
| Normal-vs-Age(81-100Yrs) |
9.75430003435918E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.287800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.148400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.003800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.408200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.262400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.946830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.2241999969298E-08 |
| Normal-VS-Type2 PRCC |
1.34336985979644E-14 |
| Normal-VS-KIRP CIMP |
1.71633999999088E-05 |
| Normal-VS-Unclassified PRCC |
3.78840000000435E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.278380E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.569000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.498000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.522800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.759000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.605800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.02062802653791E-12 |
| Normal-vs-N1 |
1.43539999997166E-06 |
| Normal-vs-N2 |
3.73770000000606E-05 |
| N0-vs-N1 |
1.412410E-01 |
| N0-vs-N2 |
3.328800E-01 |
| N1-vs-N2 |
1.413450E-01 |
|
|
